+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Astex Pharmaceuticals - logo

Astex Pharmaceuticals is a member of one of Japan's leading pharmaceutical companies, the Otsuka group. It focuses on developing small-molecule therapeutics with a focus on oncology and hematology. Its fragment-based drug discovery platform, Pyramid, has been successfully applied to therapeutic targets addressing a variety of disease areas. The company was formerly known as SuperGen Inc. and changed its name in September 2011. Astex was founded in 1991 and is headquartered in Dublin, California.

From
From
T cell Lymphoma - Pipeline Insight, 2024 - Product Thumbnail Image

T cell Lymphoma - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 250 Pages
  • Global
From
Chronic lymphocytic leukemia - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic lymphocytic leukemia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 210 Pages
  • Global
From
Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Insight, 2024 - Product Thumbnail Image

Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Neurofibrosarcoma - Pipeline Insight, 2024 - Product Thumbnail Image

Neurofibrosarcoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 120 Pages
  • Global
From
From
Hairy Cell Leukemia Therapeutics Market 2022-2026 - Product Thumbnail Image

Hairy Cell Leukemia Therapeutics Market 2022-2026

  • Report
  • June 2022
  • 120 Pages
  • Global
From
From
From
Fragment-Based Drug Discovery - Global Strategic Business Report - Product Thumbnail Image

Fragment-Based Drug Discovery - Global Strategic Business Report

  • Report
  • November 2024
  • 193 Pages
  • Global
From
From
Melanoma - Pipeline Review, H2 2020 - Product Thumbnail Image

Melanoma - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 3809 Pages
  • Global
From
Loading Indicator